Zobrazeno 1 - 10
of 23
pro vyhledávání: '"CTCs, circulating tumor cells"'
Autor:
Eleonora De Maio, Gabrielle Selmes, Slimane Zerdoud, Eva Jouve, R. Aziza, Jean-Louis Lacaze, Ciprian Chira, F. Izar, Florence Dalenc, C. Massabeau, Mony Ung, Anne Pradines
Publikováno v:
Breast, Vol 59, Iss, Pp 144-156 (2021)
The Breast : Official Journal of the European Society of Mastology
The Breast : Official Journal of the European Society of Mastology
Does oligometastatic breast cancer (OMBC) deserve a dedicated treatment? Although some authors recommend multidisciplinary management of OMBC with a curative intent, there is no evidence proving this strategy beneficial in the absence of a randomized
Autor:
Hanjie Wang, Jin Chang, Kun Ge, Jinchao Zhang, Yu Tian, Chaonan Zhang, Wang Tiange, Yingying Zhang
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 11, Iss 7, Pp 1978-1992 (2021)
Acta Pharmaceutica Sinica. B
Acta Pharmaceutica Sinica. B
Tumor recurrence after surgery is the main cause of treatment failure. However, the initial stage of recurrence is not easy to detect, and it is difficult to cure in the late stage. In order to improve the life quality of postoperative patients, an e
Autor:
Qin Guo, Chen Jiang
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 10, Iss 6, Pp 979-986 (2020)
Acta Pharmaceutica Sinica. B
Acta Pharmaceutica Sinica. B
With the development of biotherapy, biomacromolecular drugs have gained tremendous attention recently, especially in drug development field due to the sophisticated functions in vivo. Over the past few years, a motley variety of drug delivery strateg
Publikováno v:
Translational Oncology, Vol 14, Iss 4, Pp 101022-(2021)
Translational Oncology
Translational Oncology
Highlights • Chemotherapy, radiotherapy and autoimmune disorder can cause thrombocytopenia in cancer patients. • The implications of platelet transfusion on cancer progression; a “vicious circle”. • Mechanisms and signaling pathways of tumo
Autor:
Sarita Mishra, Guilhem Velve Casquillas, Jessica Ayache, Bano Subia, Ujjwal Ranjan Dahiya, Subhas C. Kundu, Rui L. Reis, David Caballero
Publikováno v:
Journal of Controlled Release
Journal of Controlled Release, Elsevier, 2021, 331, pp.103-120. ⟨10.1016/j.jconrel.2020.12.057⟩
Journal of Controlled Release, Elsevier, 2021, 331, pp.103-120. ⟨10.1016/j.jconrel.2020.12.057⟩
Breast cancer is one of the leading causes of mortality worldwide being the most common cancer among women. Despite the significant progress obtained during the past years in the understanding of breast cancer pathophysiology, women continue to die f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19a732624d3c551a56f2133b79370615
https://hal.archives-ouvertes.fr/hal-03262844
https://hal.archives-ouvertes.fr/hal-03262844
Publikováno v:
The Journal of Biological Chemistry
Cancer stem-like cells (CSCs) contribute to the high rate of tumor heterogeneity, metastasis, therapeutic resistance, and recurrence. Histone lysine demethylase 4D (KDM4D or JMJD2D) is highly expressed in colon and liver tumors, where it promotes can
Autor:
Yang, Song, Xiangfu, Guo, Jijun, Fu, Bing, He, Xueqing, Wang, Wenbing, Dai, Hua, Zhang, Qiang, Zhang
Publikováno v:
Acta Pharmaceutica Sinica. B
The dynamic or flowing tumor cells just as leukemia cells and circulating tumor cells face a microenvironment difference from the solid tumors, and the related targeting nanomedicines are rarely reported. The existence of fluidic shear stress in bloo
Autor:
Elisabetta Rossi, Angelica Zin, Paolo Bonvini, Gianni Bisogno, Rita Zamarchi, Luisa Santoro, Lucia Tombolan
Publikováno v:
Translational Oncology, Vol 13, Iss 11, Pp 100846-(2020)
Transl Oncol
Translational Oncology
Transl Oncol
Translational Oncology
EpCAM is a transmembrane glycoprotein typically overexpressed in cancer of epithelial origin and mainly involved in the epithelial-to–mesenchymal transition (EMT) of tumor cells that spread and disseminate. Strategies for the targeting and capture
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ccdf572769071249209e2445c2e5d204
http://hdl.handle.net/11577/3353828
http://hdl.handle.net/11577/3353828
Publikováno v:
Translational Oncology, Vol 14, Iss 5, Pp 101052-(2021)
Translational Oncology
Translational Oncology
Highlights 5• CTCs numbers were significantly different between malignant and benign SPNs. 5• CTCs numbers could serve as a diagnostic marker for malignant SNPs. 5• The combined use of CTCs numbers and density feature of CT morphology further i
Autor:
Catarina Abreu, Arlindo R. Ferreira, Catarina Pulido, Daniela Macedo, Luis Costa, Teresa R. Pacheco, Ines Vendrell, Sandra Casimiro, Ana Rita Sousa, M. Bettencourt, Irina Alho, André Mansinho, Adília Costa
Publikováno v:
Journal of Bone Oncology
Journal of Bone Oncology, Vol 6, Iss C, Pp 16-21 (2017)
Journal of Bone Oncology, Vol 6, Iss C, Pp 16-21 (2017)
YB-1 (Y-box binding protein 1) is a multifunctional cold-shock protein that has been implicated in all hallmarks of cancer. Elevated YB-1 protein level was associated with poor prognosis in several types of cancers, including breast cancer (BC), wher